TrialJournal of clinical pharmacology2026

Safety, Pharmacokinetics, Food effect, and Pharmacodynamics of AJM347, a Selective α4β7 Integrin Antagonist: A First-in-Human Single- and Multiple-Ascending Dose Study in Healthy Male Volunteers.

Tetsuya Koyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.